Somatic TP53 variants frequently confound germ-line testing results
- 30 November 2017
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 20 (8) , 809-816
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumor Protein p53 (TP53) Testing and Li-Fraumeni SyndromeMolecular Diagnosis & Therapy, 2013
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerNature, 2012
- Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortBreast Cancer Research and Treatment, 2012
- Genetics, genomics, and cancer risk assessmentCA: A Cancer Journal for Clinicians, 2011
- Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1)Human Mutation, 2011
- 2009 Version of the Chompret Criteria for Li Fraumeni SyndromeJournal of Clinical Oncology, 2009
- Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline MutationsJournal of Clinical Oncology, 2009
- Sensitivity and predictive value of criteria for p53germline mutation screeningJournal of Medical Genetics, 2001
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- Soft-Tissue Sarcomas, Breast Cancer, and Other NeoplasmsAnnals of Internal Medicine, 1969